Retour
Fourchette du Jour
2,47 €
2,68 €
Fourchette 52 Semaines
0,69 €
4,18 €
Volume
4 585 446
Moyenne 50J / 200J
3,18 €
/
2,62 €
Clôture Précédente
2,55 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -24,0 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -5,6 | 3,9 |
| Rev Growth 5Y % | 50,6 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
9,00 €
+243.5%
P/E Prévisionnel
35,5
BPA Prévisionnel
0,07 €
Croissance BPA (est.)
+0,0%
CA Est.
410 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,67 €
1,27 € – 2,07 €
|
1,1 B | 1 |
| FY2029 |
1,17 €
0,89 € – 1,45 €
|
880 M | 1 |
| FY2028 |
0,34 €
-0,63 € – 1,17 €
|
550 M | 3 |
Points Clés
Revenue grew 50,56% annually over 5 years — strong growth
Negative free cash flow of -12,90M
PEG of 0,56 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,25%
Capital efficient — spends only 0,05% of revenue on capex
ROIC of 18,37% — excellent capital efficiency
Croissance
Revenue Growth (5Y)
50,56%
Revenue (1Y)21,31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC18,37%
Net Margin-5,63%
Op. Margin14,95%
Sécurité
Debt / Equity
N/A
Current Ratio0,56
Interest Coverage0,71
Valorisation
P/E Ratio
-24,02
P/B RatioN/A
EV/EBITDA15,34
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,31% | Revenue Growth (3Y) | 86,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 50,56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 403,14M | Net Income (TTM) | -22,68M |
| ROE | N/A | ROA | -4,87% |
| Gross Margin | 67,95% | Operating Margin | 14,95% |
| Net Margin | -5,63% | Free Cash Flow (TTM) | -12,90M |
| ROIC | 18,37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,56 |
| Interest Coverage | 0,71 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,02 | P/B Ratio | N/A |
| P/S Ratio | 1,35 | PEG Ratio | 0,56 |
| EV/EBITDA | 15,34 | Dividend Yield | 0,00% |
| Market Cap | 544,72M | Enterprise Value | 924,87M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 403,14M | 332,31M | 116,33M | 75,48M | 78,45M |
| Net Income | -22,68M | -51,75M | -209,25M | -233,66M | -269,11M |
| EPS (Diluted) | -0,11 | -0,28 | -2,03 | -4,33 | -11,03 |
| Gross Profit | 273,91M | 263,71M | 73,07M | 48,51M | 64,23M |
| Operating Income | 60,27M | 54,40M | -155,56M | -179,50M | -226,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 465,89M | 343,82M | 205,80M | 247,94M | 381,59M |
| Total Liabilities | 767,85M | 732,54M | 660,79M | 571,72M | 578,53M |
| Shareholders' Equity | -301,97M | -388,72M | -454,99M | -323,78M | -196,94M |
| Total Debt | 548,00M | 591,21M | 540,95M | 260,95M | 260,20M |
| Cash & Equivalents | 167,85M | 144,76M | 82,25M | 124,78M | 208,89M |
| Current Assets | 167,85M | 338,00M | 201,07M | 246,68M | 328,97M |
| Current Liabilities | 300,81M | 246,23M | 156,22M | 92,31M | 73,35M |